Stephanie Manton

Stephanie Manton is an experienced professional in the fields of diagnostics and biopharma, currently serving as Venture Lead for Novonesis since January 2024, overseeing innovation and business development across various domains. Previous experience includes multiple roles at Novozymes, culminating in leadership positions focused on scouting, ventures, and corporate strategy within diagnostics, alongside research in enzymology and protein chemistry. At CiVi Biopharma, Inc., Stephanie managed pre-clinical projects and worked as a biopharmaceutical consultant. Academic pursuits encompass a postdoctoral role at Université Sorbonne Paris Cité, a visiting researcher position at the University of Cambridge, and a doctoral degree from the University of Oxford in Molecular and Cellular Medicine. Stephanie's educational background is complemented by business coursework at Columbia Business School and Copenhagen Business School, along with a Master's and Bachelor's in Chemistry from the University of Copenhagen.